| Standard | Impact on initial application | Effective date |
| IFRS 17 (Amendments) | Insurance contracts | 1 January 2023 |
| IAS 1 (Amendments) and | ||
| IFRS Practice Statement 2 | ||
| Disclosure of Accounting Policies | 1 January 2023 | |
| IAS 8 (Amendments) | Definition of Accounting Estimate | 1 January 2023 |
| IAS 12 Income Taxes | ||
| (Amendments) | ||
| Deferred Tax Related to Assets and Liabilities | ||
| Arising from a Single Transaction | ||
| 1 January 2023 | ||
| IAS 1 (Amendments) | Classification of liabilities as current or non-current | 1 January 2024 |
| IFRS 16 (Amendments) | Lease Liability in a Sale and Leaseback | 1 January 2024 |
| 2022 | ||||
| Canada | ||||
| £ | ||||
| Cyprus | ||||
| £ | ||||
| UK | ||||
| £ | ||||
| Total | ||||
| £ | ||||
| Administrative expenses | (287,458) | (168,855) | (399,586) | (855,899) |
| Impairments | (488,286) | (2,707,444) | - | (3,195,730) |
| Other income | - | - | 45,132 | |
| 45,132 | ||||
| Finance Income | - | - | (35) | |
| (35) | ||||
| Loss before tax per | ||||
| reportable segment | ||||
| (775,744) | ||||
| (2,876,299) | (354,489) | (4,006,532) | ||
| Additions/(disposal) to | ||||
| PP&E | ||||
| - | (23,816) | - | (23,816) | |
| Additions/(disposal) to | ||||
| intangible asset | ||||
| 279,898 | 182,689 | - | 462,587 | |
| Reportable segment | ||||
| assets | ||||
| 1,483,253 | 1,061,681 | 289,588 | 2,834,522 | |
| Reportable segment | ||||
| liabilities | ||||
| (12,693) | (14,574) | (109,404) | (136,671) |
| Group | ||
| 31 December | ||
| 2022 | ||
| £ | ||
| 31 December | ||
| 2021 | ||
| £ | ||
| Directors’ fees | 211,835 | 162,253 |
| Employee salaries & related expenses | 12,568 | 701 |
| Stock exchange related costs | 93,300 | 146,042 |
| Cost related to Project disposals | 155,681 | - |
| Office related expenses including printing, postage and telephone | 33,824 | 45,307 |
| Accountancy fees | 257 | 4,800 |
| Auditor remuneration | 37,214 | 30,480 |
| Travel & subsistence | 44,761 | 37,441 |
| Professional & consultancy fees | 172,944 | 224,175 |
| Insurance | 20,460 | 13,429 |
| Depreciation | 4,132 | 6,453 |
| Share Option expense | ||
| 2,100 | 135,771 | |
| Other expenses | 66,823 | 93,721 |
| Total administrative expenses | 855,899 | 900,573 |
| Group | ||
| 31 December | ||
| 2022 | ||
| £ | ||
| 31 December | ||
| 2021 | ||
| £ | ||
| Fees payable to the Company’s auditor and its associates for the audit of the Company | ||
| and Group Financial Statements | 30,000 | 30,180 |
| 2021 | ||||
| Canada | ||||
| £ | ||||
| Cyprus | ||||
| £ | ||||
| UK | ||||
| £ | ||||
| Total | ||||
| £ | ||||
| Revenue | - | - | - | - |
| Administrative | ||||
| expenses | ||||
| (6,531) | (114,072) | (779,970) | (900,573) | |
| Finance Income | - | - | (63) | (63) |
| Loss before tax per | ||||
| reportable segment | ||||
| (6,531) | (114,072) | (780,033) | (900,636) | |
| Additions to PP&E | - | 17,714 | - | 17,714 |
| Additions to intangible | ||||
| asset | ||||
| 494,020 | 932,878 | - | 1,426,898 | |
| Reportable segment | ||||
| assets | ||||
| 1,918,826 | 3,408,531 | 789,387 | 6,116,744 | |
| Reportable segment | ||||
| liabilities | ||||
| (281,747) | (121,988) | (130,931) | (534,666) |
| 31 December 2022 | ||||
| Short-term | ||||
| benefits | ||||
| Notice period | ||||
| fees | ||||
| Accruals | ||||
| Total | ||||
| £ | £ | £ | £ | |
| Executive Director | ||||
| Ajay Kejriwal | 62,000 | |||
| - | 25,000 | 87,000 | ||
| Martin French | ||||
| (1) | ||||
| 70,870 | 65,538 | - | 136,408 | |
| Paul Ensor | ||||
| (2) | ||||
| 36,000 | - | - | 36,000 | |
| Non-executive Directors | ||||
| David Cliff | 24,000 | - | - | 24,000 |
| Evengy Vrublevskiy | ||||
| - | - | - | - | |
| Peter Damouni | ||||
| (3) | ||||
| 2,500 | - | - | 2,500 | |
| 195,370 | 65,538 | 25,000 | 285,908 |
| 31 December 2021 | |||
| Short-term | |||
| benefits | |||
| Notice period | |||
| fees | Total | ||
| £ | £ | £ | |
| Executive Director | |||
| Ajay Kejriwal | 55,400 | - | 55,400 |
| Martin French | 120,000 | - | 120,000 |
| Non-executive Directors | |||
| David Cliff | 24,000 | - | 24,000 |
| Evengy Vrublevskiy | - | - | - |
| Paul Ensor | 21,700 | - | 21,700 |
| Peter Damouni | 24,000 | - | 24,000 |
| 245,100 | - | 245,100 |
| Group | ||
| 31 December | ||
| 2022 | ||
| £ | ||
| 31 December | ||
| 2021 | ||
| £ | ||
| Loss before tax | (4,006,532) | (900,636) |
| Tax at the applicable rate of 16.8% (2021: 18.1%) | (672,996) | (163,014) |
| Effects of: | ||
| Expenditure not deductible for tax purposes | 265,565 | 10,444 |
| Depreciation in excess of/(less than) capital allowances | - | 218 |
| Losses carried forward on which no deferred tax asset is recognised | 407,431 | 152,352 |
| Tax | - | - |
| Group | ||||
| Vehicles | ||||
| £ | ||||
| Office | ||||
| equipment | ||||
| £ | ||||
| Software | ||||
| £ | ||||
| Total | ||||
| £ | ||||
| Cost | ||||
| As at 1 January 2021 | 10,783 | 11,176 | 11,631 | 33,590 |
| Additions | - | 17,714 | - | 17,714 |
| Foreign exchange | (707) | (734) | - | (1,441) |
| As at 31 December 2021 | 10,076 | 28,156 | 11,631 | 49,863 |
| As at 1 January 2022 | 10,076 | 28,156 | 11,631 | 49,863 |
| Additions | - | 5,225 | - | 5,225 |
| Disposal | (10,630) | (18,411) | - | (29,041) |
| Foreign exchange | 554 | 1,548 | - | 2,102 |
| As at 31 December 2022 | - | 16,518 | 11,631 | 28,149 |
| Depreciation | ||||
| As at 1 January 2021 | 6,470 | 3,929 | 10,484 | 20,883 |
| Charge for the year | 2,015 | 3,291 | 1,147 | 6,453 |
| Foreign exchange | (424) | (258) | - | (682) |
| As at 31 December 2021 | 8,061 | 6,962 | 11,631 | 26,654 |
| As at 1 January 2022 | 8,061 | 6,962 | 11,631 | 26,654 |
| Disposal | (9,567) | (2,837) | - | (12,404) |
| Charge for the year | 1,063 | 3,069 | - | 4,132 |
| Foreign exchange | 443 | 383 | - | 826 |
| As at 31 December 2022 | - | 7,577 | 11,631 | 19,208 |
| Net book value as at 31 December 2021 | 2,015 | 21,194 | - | 23,209 |
| Net book value as at 31 December 2022 | - | 8,941 | - | 8,941 |
| Company | ||
| Software | ||
| £ | ||
| Total | ||
| £ | ||
| Cost | ||
| As at 1 January 2021 | 11,631 | 11,631 |
| Additions | - | - |
| As at 31 December 2021 | 11,631 | 11,631 |
| As at 1 January 2022 | 11,631 | 11,631 |
| Additions | - | - |
| As at 31 December 2022 | 11,631 | 11,631 |
| Depreciation | ||
| As at 1 January 2021 | 10,484 | 10,484 |
| Charge for the period | 1,147 | 1,147 |
| As at 31 December 2021 | 11,631 | 11,631 |
| As at 1 January 2022 | 11,631 | 11,631 |
| Charge for the period | - | - |
| As at 31 December 2022 | 11,631 | 11,631 |
| Net book value as at 31 December 2021 | - | - |
| Net book value as at 31 December 2022 | - | - |
| Group | ||
| Exploration & Evaluation Assets - Cost and Net Book Value | ||
| 2022 | ||
| £ | ||
| 2021 | ||
| £ | ||
| Opening balance | 5,008,562 | 2,433,876 |
| Additions | 462,587 | 1,426,898 |
| Fair value uplift of Chesterfield (Canada) Inc. acquisition | - | 1,264,164 |
| Impairment of Chesterfield (Canada) Inc asset | (488,286) | - |
| Impairment of Chesterfield Resources (Cyprus) Ltd asset | (2,707,444) | - |
| Reclassify to Asset Held for Sale (note 13) | (1,478,287) | - |
| Foreign exchange | 83,705 | (116,376) |
| As at end of period | 880,837 | 5,008,562 |
| Company | ||
| 2022 | ||
| £ | ||
| 2021 | ||
| £ | ||
| Shares in Group Undertakings | ||
| At beginning of period | 1,511,332 | 500,000 |
| Investment in Chesterfield (Canada) Inc. | - | 1,011,332 |
| Impairment of Investment in Chesterfield (Canada) Inc. | (241,060) | - |
| Investment in Chesterfield Resources (Cyprus) Ltd | - | - |
| At end of period | 1,270,272 | 1,511,332 |
| Loans to Group undertakings | ||
| At beginning of period | 3,819,127 | 1,951,046 |
| Loans granted | 242,352 | 1,648,379 |
| Foreign Exchange | 213,221 | 159,016 |
| Interest receivable | 55,017 | 60,686 |
| Impairment of Loan to Chesterfield Resources (Cyprus) Ltd | (3,146,225) | - |
| At end of period | 1,183,492 | 3,819,127 |
| Total | 2,453,764 | 5,330,459 |
| Name of subsidiary | Registered office address | ||||
| Country of | |||||
| incorporation | |||||
| and place of | |||||
| business | |||||
| Proportion of | |||||
| ordinary | |||||
| shares held | |||||
| by parent (%) | |||||
| Proportion of | |||||
| ordinary shares | |||||
| held by the | |||||
| Group (%) | |||||
| Nature of | |||||
| business | |||||
| CRC Chesterfield | |||||
| Resources (Cyprus) | |||||
| Limited | |||||
| Illoupoleos 1, Germasogela, | |||||
| 4046 Limassol, Cyprus | |||||
| Cyprus | 100% | 100% | Exploration | ||
| Chesterfield (Canada) | |||||
| Inc | |||||
| PO Box 5038. St John’s, | |||||
| Canada | |||||
| Canada | 100% | 100% | Exploration |
| Group | Company | |||
| Current | ||||
| 31 December | ||||
| 2022 | ||||
| £ | ||||
| 31 December | ||||
| 2021 | ||||
| £ | ||||
| 31 December | ||||
| 2022 | ||||
| £ | ||||
| 31 | ||||
| December | ||||
| 2021 | ||||
| £ | ||||
| Prepayments | 13,231 | 136,869 | 9,406 | 18,342 |
| Other receivables | 32,601 | 31,804 | 565,227 | - |
| Amounts due from group undertakings | - | - | - | 101,127 |
| VAT receivable | 116,603 | 153,330 | 4,374 | 11,065 |
| Total | 162,435 | 322,003 | 579,007 | 130,534 |
| Group | Company | |||
| 31 December | ||||
| 2022 | ||||
| £ | ||||
| 31 December | ||||
| 2021 | ||||
| £ | ||||
| 31 December | ||||
| 2022 | ||||
| £ | ||||
| 31 | ||||
| December | ||||
| 2021 | ||||
| £ | ||||
| Cash at bank and in hand | 304,022 | 762,971 | 275,813 | 759,978 |
| Group | ||
| 2022 | ||
| £ | ||
| 2021 | ||
| £ | ||
| Deferred tax liabilities | ||
| Acquisition of subsidiary | 380,283 | 380,283 |
| Derecognised on impairment of Intangible Asset in Canada | (252,832) | - |
| Derecognised on impairment of Intangible Asset in Cyprus | (94,313) | - |
| 33,138 | - |
| Group | Company | |||
| 31 December | ||||
| 2022 | ||||
| £ | ||||
| 31 December | ||||
| 2021 | ||||
| £ | ||||
| 31 December | ||||
| 2022 | ||||
| £ | ||||
| 31 December | ||||
| 2021 | ||||
| £ | ||||
| Trade payables | 9,493 | 115,925 | 21,963 | 98,179 |
| Accruals | 61,600 | 31,403 | 55,000 | 25,697 |
| Other payables | 32,440 | 7,055 | 32,440 | 7,056 |
| 103,533 | 154,383 | 109,403 | 130,932 |
| Group | 31 December 2022 | 31 December 2021 | ||
| Loans & | ||||
| receivables | ||||
| Total | ||||
| Loans & | ||||
| receivables | ||||
| Total | ||||
| Assets per Statement of Financial Performance | ||||
| (Amortised cost) | ||||
| £ | £ | £ | £ | |
| Trade and other receivables (excluding | ||||
| prepayments and VAT) | ||||
| 32,601 | 32,601 | 31,804 | 31,804 | |
| Cash and cash equivalents | 304,022 | 304,022 | 762,971 | 762,971 |
| 336,623 | 336,623 | 794,755 | 794,755 |
| 31 December 2022 | 31 December 2021 | |||
| At amortised | ||||
| cost | ||||
| Total | ||||
| At amortised | ||||
| cost | ||||
| Total | ||||
| Liabilities per Statement of Financial | ||||
| Performance | ||||
| (Amortised cost) | ||||
| £ | £ | £ | £ | |
| Trade and other payables (excluding non-financial | ||||
| liabilities) | ||||
| 41,933 | ||||
| 41,067 | ||||
| 122,980 | ||||
| 122,980 | ||||
| 41,933 | 41,067 | 122,980 | 122,980 |
| Company | 31 December 2022 | 31 December 2021 | ||
| Loans & | ||||
| receivables | ||||
| Total | Loans & receivables | Total | ||
| Assets per Statement of Financial | ||||
| Performance (Amortised cost) | ||||
| £ | £ | £ | £ | |
| Trade and other receivables (excluding | ||||
| prepayments and VAT) | ||||
| 565,227 | ||||
| 565,227 | ||||
| 101,127 | ||||
| 101,127 | ||||
| Cash and cash equivalents | 275,813 | 275,813 | 759,978 | 759,978 |
| 841,040 | 841,040 | 861,105 | 861,105 |
| At amortised | ||||
| cost | ||||
| Total | ||||
| At amortised | ||||
| cost | ||||
| Total | ||||
| Liabilities per Statement of Financial | ||||
| Performance | ||||
| (Amortised cost) | ||||
| £ | £ | £ | £ | |
| Trade and other payables (excluding | ||||
| non-financial liabilities) | ||||
| 54,403 | ||||
| 54,403 | ||||
| 105,235 | ||||
| 105,235 | ||||
| 54,403 | 54,403 | 105,235 | 105,235 |
| Number of shares | ||||
| authorised, | ||||
| issued and fully | ||||
| paid | ||||
| Share Capital | ||||
| £ | ||||
| Share premium | ||||
| £ | ||||
| Total | ||||
| £ | ||||
| As at 1 January 2021 | 101,711,112 | 199,711 | 6,482,931 | 6,682,642 |
| As at 31 December 2021 | 120,328,311 | 218,328 | 8,253,634 | 8,471,962 |
| As at 1 January 2022 | 120,328,311 | 218,328 | 8,253,634 | 8,471,962 |
| 2 February 2022 – shares issued | ||||
| (1) | ||||
| 10,000,000 | 10,000 | 666,020 | 676,020 | |
| As at 31 December 2022 | 130,328,311 | 228,328 | 8,919,654 | 9,147,982 |
| Options & Warrants | ||||
| Grant Date | Expiry Date | Exercise price in £ per share | ||
| 31 December | ||||
| 2022 | ||||
| 31 December | ||||
| 2021 | ||||
| 16 March 2017 | 29 August 2022 | 0.05 | - | 5,000,000 |
| 28 June 2018 | 2 July 2023 | 0.75 | 1,805,000 | 1,805,000 |
| 17 December 2019 | 1 January 2025 | 0.05 | 1,800,000 | 1,800,000 |
| 27 July 2020 | 3 July 2023 | 0.0525 | 2,565,000 | 2,565,000 |
| 27 July 2020 | 27 July 2025 | 0.0525 | 2,175,000 | 2,175,000 |
| 27 July 2020 | 16 July 2025 | 0.10 | 619,333 | 619,333 |
| 26 November 2020 | 26 November 2025 | 0.09 | 1,000,000 | 1,000,000 |
| 11 December 2020 | 11 December 2025 | 0.09 | 55,556 | 55,556 |
| 5 January 2021 | 5 January 2026 | 0.14 | 1,400,000 | 1,400,000 |
| 5 February 2021 | 5 February 2026 | 0.125 | 250,000 | 250,000 |
| 2 July 2021 | 2 July 2026 | 0.12 | 2,400,000 | 2,400,000 |
| 2 July 2021 | 2 July 2024 | 0.20 | 11,100,000 | 11,100,000 |
| 30 September 2021 | 30 September 2026 | 0.11 | 2,200,000 | 2,200,000 |
| 16 February 2022 | 16 February 2024 | 0.12 | 5,029,000 | - |
| 32,398,889 | 32,369,889 |
| 2020 Options | 2020 Options | 2019 Options | 2018 Options | |
| Granted on: | 27/07/202 | 0 27/07/2020 | 17/12/2019 | 28/06/2018 |
| Life (years) | 5 years | 3 years | 5 years | 4.5 years |
| Exercise price (pence per share) | 5.25p | 5.25p | 5p | 7.5p |
| Risk free rate | 0.08% | 0.08% | 0.4% | 0.5% |
| Expected volatility | 43.70% | 43.70% | 12.96% | 14.33% |
| Expected dividend yield | - | - | - | - |
| Marketability discount | 20% | 20% | 20% | 20% |
| Total fair value (£000) | 69 | 63 | 0.378 | 11 |
| 2021 Options | 2020 Options | 2020 Options | 2020 Options | |
| Granted on: | 05/01/2021 | 11/12/2020 | 26/11/2020 | 27/07/2020 |
| Life (years) | 5 years | 5 years | 5 years | 5 years |
| Exercise price (pence per share) | 14p | 9p | 9p | 10p |
| Risk free rate | 0.08% | 0.08% | 0.08% | 0.08% |
| Expected volatility | 35.43% | 27.23% | 27.23% | 43.70% |
| Expected dividend yield | - | - | - | - |
| Marketability discount | 20% | 20% | 20% | 20% |
| Total fair value (£000) | 50 | 3 | 27 | 10 |
| 2021 Options | 2021 Options | 2021 Options | 2021 Options | |
| Granted on: | 02/07/2021 | 02/07/2021 | 02/07/2021 | 05/02/2021 |
| Life (years) | 3 years | 1 years | 5 years | 5 years |
| Exercise price (pence per share) | 20p | 5p | 12p | 12.5p |
| Risk free rate | 1.10% | 1.02% | 1.10% | 0.08% |
| Expected volatility | 13.79% | 13.79% | 13.79% | 35.43% |
| Expected dividend yield | - | - | - | - |
| Marketability discount | 20% | 20% | 20% | 20% |
| Total fair value (£000) | 2.5 | 41 | 32.5 | 8 |
| 2021 Options | 2022 Options | 2022 Options | |
| Granted on: | 30/09/2021 | 03/01/2022 | 16/02/2022 |
| Life (years) | 5 years | 4 years | 2 years |
| Exercise price (pence per share) | 11p | 7p | 12p |
| Risk free rate | 1.10% | 1.95% | 2.12% |
| Expected volatility | 12.29% | 14.63% | 12.92% |
| Expected dividend yield | - | - | - |
| Marketability discount | 20% | 20% | 20% |
| Total fair value (£000) | 3.5 | 2.0 | - |
| 2022 | 2021 | |||
| Number | ||||
| Weighted | ||||
| average | ||||
| exercise price | ||||
| (£) | ||||
| Number | ||||
| Weighted | ||||
| average | ||||
| exercise price | ||||
| (£) | ||||
| Outstanding at beginning of period | 32,369,889 | 0.11 | 15,969,889 | 0.058 |
| Granted | 5,129,000 | 0.12 | 18,100,000 | 0.17 |
| Exercised | - | - | (528,000) | 0.058 |
| Expired/cancelled | (5,100,000) | 0.11 | (1,172,000) | 0.058 |
| Outstanding as at period end | 32,398,889 | 0.13 | 32,369,889 | 0.11 |
| Exercisable at period end | 32,398,889 | 0.13 | 32,369,889 | 0.11 |
| 2022 | 2021 | |||||||
| Range of | ||||||||
| exercise | ||||||||
| prices (£) | ||||||||
| Weighted | ||||||||
| average | ||||||||
| exercise | ||||||||
| price (£) | ||||||||
| Number of | ||||||||
| shares | ||||||||
| Weighted | ||||||||
| average | ||||||||
| remaining | ||||||||
| life | ||||||||
| expected | ||||||||
| (years) | ||||||||
| Weighted | ||||||||
| average | ||||||||
| remaining | ||||||||
| life | ||||||||
| contracted | ||||||||
| (years) | ||||||||
| Weighted | ||||||||
| average | ||||||||
| exercise | ||||||||
| price (£) | ||||||||
| Number of | ||||||||
| shares | ||||||||
| Weighted | ||||||||
| average | ||||||||
| remaining | ||||||||
| life | ||||||||
| expected | ||||||||
| (years) | ||||||||
| Weighted | ||||||||
| average | ||||||||
| remaining | ||||||||
| life | ||||||||
| contracted | ||||||||
| (years) | ||||||||
| 0 – 0.05 | 0.05 | 1,800,000 | 2.01 | 2.01 | 0.05 | 6,800,000 | 1.16 | 1.16 |
| 0.06 – 0.15 | ||||||||
| 0.09 | 13,248,889 | 1.39 | 1.42 | |||||
| 0.07 | 8,219,889 | 2.51 | 2.51 | |||||
| 0.16 – 0.30 | ||||||||
| 0.17 | 17,350,000 | 2.07 | 2.07 | |||||
| 0.17 | 17,350,000 | 3.20 | 3.20 |
| Company | ||
| 31 December | ||
| 2022 | ||
| £ | ||
| 31 December | ||
| 2021 | ||
| £ | ||
| CRC Chesterfield Resources (Cyprus Limited) | 475,476 | 3,168,951 |
| Chesterfield (Canada) Inc. | 708,016 | 650,176 |
| At 31 December | 1,183,492 | 3,819,127 |
| Group | |||
| Group | |||
| License fees | |||
| £ | |||
| Minimum | |||
| spend | |||
| requirement | |||
| £ | |||
| Total | |||
| £ | |||
| Not later than one year | |||
| 17,469 | 97,442 | 114,911 | |
| Later than one year and no later than five years | 69,875 | 487,212 | 557,087 |
| Total | 87,344 | 584,654 | 671,998 |
| Consideration at 7 July 2021 | |
| £ | |
| Equity instruments in issue (10,089,199 ordinary shares £0.10 each) | 1,008,920 |
| Warrant instruments (11,100,000 ordinary shares £0.10 each) | 2,412 |
| Total consideration | 1,011,332 |
| Recognise amounts of identifiable assets acquired and liabilities assumed | |
| Cash and cash equivalents | - |
| Trade and other receivables | - |
| Trade and other payables | - |
| Total identified net assets | - |
| Deferred tax liability | (252,832) |
| Fair value uplift | 1,264,164 |